Clinical Characteristics and Metabolomics Investigation for Patients with Dengue Virus 2 Infection

Jiepeng Tong,Zhe Wu,Jiajie Zhang,Li Zhang,Wei Yu,Yunqing Qiu
DOI: https://doi.org/10.21203/rs.3.rs-617844/v1
2021-01-01
Abstract:Abstract OBJECTIVES Dengue is an endemic viral disease affecting tropical and subtropical regions around the world. The aim of this study was to retrospectively study the clinical characteristics of dengue fever (DF) and evaluate the metabolomic changes. METHODS The medical records of 50 patients presented with dengue virus 2 (DENV-2) RNA positive were reviewed. Serum was collected from 20 patients diagnosed with DF and 20 healthy volunteers. The changes in serum metabolites were explored by UPLC-Q-TOF MS spectrometer. RESULTS Fever, nausea and vomiting, asthenia, skin hyperemia were the most common clinical symptoms. The results of the laboratory examinations showed that leukopenia (76%, 38/50), thrombocytopenia (92%, 46/50), increase of aspartate aminotransferase (96%, 48/50), increase of free fatty acids (FFA) (68%, 34/50), increase of creatine kinase (CK) (44%, 22/50) were more common. Based on orthogonal projection to latent structures-discriminant analysis (OPLS-DA), 2 up-regulated and 15 down-regulated metabolites were identified, contributing to DF progress to some extent. Among them, LysoPC (18:2(9Z,12Z)) were highly positive correlated with PE (21:0/20:5(5Z,8Z,11Z,14Z,17Z)) and 13'-Hydroxy-alpha-tocopherol. The identified biomarkers were mainly involved in glycerophospholipids metabolism pathway. CONCLUSIONS The metabolic abnormalities of glycerophospholipids involved in the occurrence of DF caused by DENV-2.
What problem does this paper attempt to address?